Business of Bioanalysis: Investing in Technology Implementation

Watch Dr. Afshin Safavi, BioAgilytix Global CSO discuss the costs to consider beyond the initial purchase price of a bioanalytical platform as part of the “Business of Bioanalysis” panel hosted by Bioanalysis Zone.

*Video Produced by Bioanalysis Zone

Share This